Vyvanse
![Takeda, Vyvanse, Generic, Attention-deficit hyperactivity disorder, ADHD](https://pharmtales.com/wp-content/uploads/2023/08/Takedas-Vyvanse-faces-generic-competition-after-16-years-of-ADHD-dominance.jpg)
Takeda’s Vyvanse faces generic competition after 16 years of ADHD dominance
Anika Sharma
Vyvanse, a blockbuster drug for attention-deficit/hyperactivity disorder (ADHD) and binge-eating disorder, has been the top choice for many patients and ...
![Takeda Hypes Dengue Vaccine to Offset Vyvanse Loss](https://pharmtales.com/wp-content/uploads/2023/07/As-Vyvanse-generics-loom-Takeda-exaggerates-the-progress-of-the-dengue-vaccine-launch.jpg)
As Vyvanse generics loom, Takeda exaggerates the progress of the dengue vaccine launch
SG Tylor
As generics of the popular ADHD medication Vyvanse loom on the horizon, Takeda is looking to rely on newer launches ...
![Vyvanse Joins Adderall in Short Supply as Takeda's Rival Faces Shortages](https://pharmtales.com/wp-content/uploads/2023/06/Vyvanse-Joins-Adderall-in-Short-Supply-as-Takedas-Rival-Faces-Shortages.jpg)
Vyvanse Joins Adderall in Short Supply as Takeda’s Rival Faces Shortages
SG Tylor
Source – Fierce Pharma A competitor medication from Takeda is currently in low supply after a lengthy scarcity of the ...